Don't just take our word for it.
Independent, peer-reviewed research has consistently demonstrated the patient safety and financial impacts of false positive blood cultures. Increased costs for pharmacy, laboratory, microbiology, diagnostic imagining, and other tests and treatments, coupled with extended inpatient length of stay, drive undesirable patient outcomes and unnecessary hospital expenses.
Clinical Study Validates the SteriPath Blood Culture Collection System to Reduce Blood Culture Contamination to 0.2%
Mark E Rupp, R Jennifer Cavalieri, Cole Marolf, Elizabeth Lyden; Reduction in Blood Culture Contamination Through Use of Initial Specimen Diversion Device. Clin Infect Dis 2017 cix304. doi: 10.1093/cid/cix304.
The results of a 13-month, matched-pair clinical study demonstrated an 88% lower blood culture contamination rate with the use of SteriPath. SteriPath delivered a sustained contamination rate of 0.2% versus a contamination rate of 1.78% from traditional blood culture collection methods.Read More >
SteriPath Prevents Blood Culture Contamination
Rupp, M., Cavalieri, R., Lyden, E. Initial Specimen Diversion Device (ISDD) Prevents Blood Culture Contamination. University of Nebraska Medical Center, Omaha, NE. Presented October 2016 at IDWeek.
Results from a 971 patient prospective matched-pair formal clinical trial demonstrating 88% lower blood culture contamination using SteriPath compared to standard of care. Sustained contamination rate of 0.2% over a 13-month period was achieved in investigational SteriPath arm of trial.Read More >
SteriPath Demonstrates a 90% Reduction in Blood Culture Contamination
Huss, J, C. Lanteri, R. Ybarra. Reducing Blood Culture Contamination with the SteriPath Blood Collection Kit. US Army, San Antonio Military Medical Center, 2016.
Results from a 1,888 culture study comparing SteriPath versus the standard method of blood culture collection conducted at the Brook Army Medical Center (BAMC). SteriPath demonstrated a 90% lower blood culture contamination from the standard of care.Read More >
86% Lower False-Positive Blood Culture Rate Achieved with SteriPath
Lori L Gauld, MT(ASCP), SM(ASCP), Gloria E PalmerLong, SM(ASCP), Stefani Michael, RN, Lisa L Steed, PhD, (ABMM). Reducing the Laboratory Cost of False Positive Blood Cultures in the Adult Emergency Department. Presented at IHI’s 28th Annual National Forum on Quality Improvement in Health Care. Orlando, FL, December 2016.
8-month prospective comparison of SteriPath vs. standard aseptic procedure for blood culture collection. 86.3% reduction in false-positive results for cultures collected with SteriPath and estimated cost savings of $194,486 during the evaluation period.Read More >
Performance of the SteriPath Device in Removing Skin Contamination from Blood Culture Samples
Parul Patel, BS MT(ASCP), CCRP, Donna Schora, MT(ASCP), Richard Thomson Jr., PhD and Lance Peterson, MD, FIDSA, FSHEA, NorthShore University HealthSystem, Evanston, IL
Study confirms that a diversion device, such as SteriPath, can significantly lower blood culture contamination rates.Read More >
Impact of blood cultures drawn by phlebotomy on contamination rates and health care costs in a hospital emergency department.
Gander, R. M., L. Byrd, M. DeCrescenzo, S. Hirany, M. Bowen, and J. Baughman
J. Clin. Microbiol. April 2009, p. 1021-1024, Vol. 47, No. 4
Gander et al evaluated contamination rates for phlebotomy as well as non-phelobotomy staff looking at incremental cost and extension of hospital stay attributable to false-positive cultures.Read More >
Contaminant blood cultures and resource utilization: the true consequences of false-positive results.
Bates, DW; Goldman L; Lee TII
JAMA, January 1991, pp. 365-369, Vol. 265 No. 3
In this study, Bates et al examine the impacts of false-positive blood cultures by analyzing the typical treatment response, associated costs, average increase in hospital stays, etc.Read More >
Trends in Blood Culture Contamination: A College of American Pathologists Q-Tracks Study of 356 Institutions
Bekeris et al
Archives of Pathology and Laboratory Medicine, October 2005, pp. 1222–1225. Vol. 129, No. 10
Study analyzes the impact of dedicated laboratory phlebotomists vs. non-laboratory personnel collecting blood samples on contamination rates. The research also evaluates the financial impact of false-blood cultures by performing charge-to-cost and inflation adjustments to the analysis conducted by Bates et al in 1991.Read More >
Updated Review of Blood Culture Contamination
Hall, KH; Lyman, JA
Clinical Microbiology Reviews, October 2006, pp. 788-802, Vol. 19, No. 4
Comprehensive review of blood culture contamination subject with one-hundred sixty-one (161) references. The review includes details of current known detection and prevention methods.Read More >
Clinical and economic impact of contaminated blood cultures within the hospital setting.
Alahmadi Y.M, M.A. Aldeyab, J.C. McElnay, M.G. Scott, F.A. Magee, et al
J Hosp Infect. 2011 Mar;77(3):233-6. doi: 10.1016/j.jhin.2010.09.033. Epub 2011 Jan 7
The objective of the present investigation was to determine the impact of the false-positive blood culture results on the following outcomes: length of stay, hotel costs, antimicrobial costs, and costs of laboratory and radiological investigation.Read More >
Analysis of strategies to improve cost effectiveness of blood cultures.
Zwang O., R.K. Albert
Journal of Hosp Med. 2006 Sep;1(5):272-6
Despite there being nearly 15 times as many true-negative blood cultures as false positive ones, far greater improvements in resource utilization would result from reducing the number of contaminated blood cultures than by reducing the number of true negatives.Read More >
Phlebotomy teams reduce blood-culture contamination rate and save money.
Surdulescu, S., D. Ultamsingh, and R. Sheker
Clin. Perform. Qual. Health Care. 6:60-62, 1998
This study demonstrated a substantial increase in resource utilization in our hospital due to contaminated blood cultures. The reinstitution of a phlebotomy team could be a cost-effective solution with savings between $950,000 and $1.5 million per year for our hospital.Read More >
Antimicrobial misuse in patients with positive blood cultures.
Dunagan W.C., R.S. Woodward, G. Medoff, J. L. Grey, E. Casabar, M. D. Smith, C. A. Lawrenz and E. Spitznagel
The American Journal of Medicine. Volume 87, Issue 3 , Pages 253-259, September 1989
Inappropriate antimicrobial use was examined among a randomly and prospectively selected cohort of patients with at least one positive result of blood cultures. This misuse was then analyzed with respect to hospital charges and length of stay (LOS).Read More >